Another RS and the price level becomes respectable for this techno-healthcare company. A respectable ticker price could possibly bring in larger investors and get us back to Nasdaq, where we belong. At least on the Nasdaq we would ALL get to short sell it. ;-) $RNVA
Market Data 
Markets 
AI
